{
    "url": "https://nationalscreening.blog.gov.uk/2024/03/14/english-government-endorses-recommendation-to-screen-newborns-for-tyrosinaemia/",
    "title": "English government endorses recommendation to screen newborns for tyrosinaemia",
    "authors": [
        "Mike Harris"
    ],
    "categories": [
        "General"
    ],
    "pub_date": "2024-03-14T10:28:28+00:00",
    "content": [
        {
            "text": "The English government has endorsed the UK National Screening Committee's (UK NSC\u2019s) recommendation to introduce newborn screening for hereditary tyrosinaemia type 1 (HT1), a rare genetic condition."
        },
        {
            "text": "HT1 prevents the body breaking down a substance called tyrosine found in food and affects approximately 7 babies per year in the UK. Untreated, it can lead to severe complications such as liver and kidney damage, and in some cases the need for a liver transplant."
        },
        {
            "text": "HT1 will be added to the conditions screened for by the NHS Newborn Blood Spot Screening Programme in England.\u00a0This will potentially find an additional 3 babies a year who can be offered drug treatment and a special diet before they become symptomatic, reducing the chance of liver disease and the need for liver transplantation."
        },
        {
            "text": "The English government\u2019s endorsement of the UK NSC\u2019s recommendation is part of its commitment to improve the lives of people living with rare diseases, which is set out in the England Rare Diseases Action Plan."
        },
        {
            "text": "UK NSC chair Professor Sir Mike Richards:"
        },
        {
            "text": "View the UK NSC\u2019s full recommendation along with the English government\u2019s impact assessment and equality impact assessment of introducing this policy."
        }
    ]
}